Tissue inhibitor of metalloproteinase 3 exerts its anti-proteolytic function either at the invasion front of an infiltrating HNSCC to quench tumour-associated ECM degrading activity or in the stroma itself, where soluble proteases liberate ECM-tethered factors that assist the cancer cell in migration and invasion. Here, TIMP3 is linked to head and neck squamous cell carcinoma.